Torgeir Vaage
Directeur Financier/CFO chez INITIATOR PHARMA A/S
Profil
Torgeir Vaage is the founder of Caerus Consulting AS, which was founded in 2009.
He is currently the Chief Executive Officer of GeneSeque AS, Chairman & Managing Director of Caerus Capital AS, and Chief Financial Officer of Initiator Pharma A.
Dr. Vaage has previously worked as a Principal at ABG Sundal Collier Holding ASA and Handelsbanken Markets Norge, as well as Chief Financial Officer at Sana Pharma Medical AS and Chief Operating Officer at VoluSense AS.
He holds a doctorate degree from the University of California, Berkeley and a graduate degree from the Norwegian School of Economics & Business Administration.
Postes actifs de Torgeir Vaage
| Sociétés | Poste | Début |
|---|---|---|
| INITIATOR PHARMA A/S | Directeur Financier/CFO | 01/01/2016 |
Caerus Capital AS
 Caerus Capital AS Pharmaceuticals: MajorHealth Technology Caerus Capital AS develops a process to produce heparin from marine raw materials. It focuses on developing novel anticoagulant agents based on biomass from the fish farming industry. The firm's technological platform is based on patented processes for extraction and purification of heparin using marine species-specifically salmon intestines-as raw material. The company was founded by Ragnar Flengsrud on December 4, 2001 and is headquartered in Hovik, Norway. | Directeur Général | - |
Caerus Consulting AS
 Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Directeur Général | 31/03/2009 |
GeneSeque AS
 GeneSeque AS Medical SpecialtiesHealth Technology GeneSeque AS provides single-molecule DNA-sequencing technology. It develops MagSeq, a break-through technology for single-molecule sequencing. The company was founded on February 12, 2008 and is headquartered in Trondheim, Norway. | Directeur Général | - |
Anciens postes connus de Torgeir Vaage
| Sociétés | Poste | Fin |
|---|---|---|
VoluSense AS
 VoluSense AS Medical SpecialtiesHealth Technology VoluSense AS manufactures medical devices focused on pulmonary health. It offers VoluSense Pediatrics in the neonatal unit for the infants that provides visual and quantitative information on tidal flow, tidal volume, minute volume, and respiration frequency. The company was founded by Kjell Gunnar Øygarden and is headquartered in Bergen, Norway. | Directeur des opérations | - |
| ABG SUNDAL COLLIER HOLDING ASA | Corporate Officer/Principal | - |
Handelsbanken Markets Norge
 Handelsbanken Markets Norge Investment Banks/BrokersFinance Part of Svenska Handelsbanken AB, Handelsbanken Markets Norge is a Norwegian company that provides security brokerage services. | Corporate Officer/Principal | - |
Sana Pharma Medical AS
 Sana Pharma Medical AS Pharmaceuticals: MajorHealth Technology Sana Pharma Medical AS develops topical analgesic products. It develops products against various chronic pain conditions, including osteoarthritis of the knee. Its product 2PX provides clinical benefit in the management of both nociceptive and neuropathic pain. The company was founded in 2002 and is headquartered in Oslo, Norway. | Directeur Financier/CFO | - |
Formation de Torgeir Vaage
| Norwegian School of Economics & Business Administration | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABG SUNDAL COLLIER HOLDING ASA | Finance |
| INITIATOR PHARMA A/S | Health Technology |
| Entreprise privées | 6 |
|---|---|
Sana Pharma Medical AS
Sana Pharma Medical AS Pharmaceuticals: MajorHealth Technology Sana Pharma Medical AS develops topical analgesic products. It develops products against various chronic pain conditions, including osteoarthritis of the knee. Its product 2PX provides clinical benefit in the management of both nociceptive and neuropathic pain. The company was founded in 2002 and is headquartered in Oslo, Norway. | Health Technology |
Handelsbanken Markets Norge
Handelsbanken Markets Norge Investment Banks/BrokersFinance Part of Svenska Handelsbanken AB, Handelsbanken Markets Norge is a Norwegian company that provides security brokerage services. | Finance |
Caerus Capital AS
Caerus Capital AS Pharmaceuticals: MajorHealth Technology Caerus Capital AS develops a process to produce heparin from marine raw materials. It focuses on developing novel anticoagulant agents based on biomass from the fish farming industry. The firm's technological platform is based on patented processes for extraction and purification of heparin using marine species-specifically salmon intestines-as raw material. The company was founded by Ragnar Flengsrud on December 4, 2001 and is headquartered in Hovik, Norway. | Health Technology |
Caerus Consulting AS
Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Health Technology |
VoluSense AS
VoluSense AS Medical SpecialtiesHealth Technology VoluSense AS manufactures medical devices focused on pulmonary health. It offers VoluSense Pediatrics in the neonatal unit for the infants that provides visual and quantitative information on tidal flow, tidal volume, minute volume, and respiration frequency. The company was founded by Kjell Gunnar Øygarden and is headquartered in Bergen, Norway. | Health Technology |
GeneSeque AS
GeneSeque AS Medical SpecialtiesHealth Technology GeneSeque AS provides single-molecule DNA-sequencing technology. It develops MagSeq, a break-through technology for single-molecule sequencing. The company was founded on February 12, 2008 and is headquartered in Trondheim, Norway. | Health Technology |
